Skip to content

Triathlon PKR Study in Japan

A Prospective, Single Arm, Multi Center Study on the Compatibility of Triathlon PKR and the Motion Analysis for Japanese

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02552095
Enrollment
63
Registered
2015-09-16
Start date
2013-06-30
Completion date
2018-09-30
Last updated
2018-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee

Brief summary

The Purpose of this study is to evaluate compatibility of the Triathlon Partial Knee Replacement (PKR) with the Japanese population. It is expected that patients who receive the Triathlon PKR will achieve excellent clinical results without adverse effects and that the device fits well with Japanese morphology.

Interventions

Sponsors

Stryker Japan K.K.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. Patient requires a primary unicompartmental knee replacement. 2. Patient is between 20 years old to 80 years old. 3. Patient is diagnosed as osteoarthritis, rheumatoid arthritis, traumatic arthritis or avascular necrosis. 4. Patient can walk independently at least 10m. 5. Patient has signed the Institutional Review Board (IRB) approved, study specific informed patient consent form. 6. Patient is willing and able to comply with post-operative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

1. Patient requires a revision. 2. Patient is pregnant. 3. Patient has lateral osteoarthritis. 4. Patient has less than 10°of flexion contracture and greater than 90°of flexion. 5. Patient's preoperative mechanical alignment is less than 10° of varus and 15° of valgus. 6. Patient has had high tibial osteotomy, femoral osteotomy and/or joint fusion. 7. Patient has a neuromuscular or neurosensory deficiency that would limit the ability to assess the performance of the device. 8. Patient has a systemic or metabolic disorder leading to progressive bone deterioration. 9. Patient is immunologically suppressed or receiving steroids (\>30 days) in excess of normal physiological requirements. 10. Patient has a deformity which will require the use of wedges or augments. 11. Patient has an active or suspected latent infection in or about the knee joint. 12. Patient who is inappropriate for participating in the study by the judgment of the investigator.

Design outcomes

Primary

MeasureTime frame
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)Pre-operation, 6 months, 12 months and 24 months after surgery

Secondary

MeasureTime frame
Measurement of tibial resection plane (A-P length and width of resection)intraoperative
Change in Quality of life as assessed by 12-Item Short-Form Health Survey (SF-12) questionnairePre-operation, 6 months, 12 months and 24 months after surgery
Change in Japanese Orthopaedics Association (JOA) scorePre-operation, 6 months, 12 months and 24 months after surgery

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026